Search for: "Ranbaxy Pharmaceuticals, Inc. "
Results 41 - 60
of 101
Sorted by Relevance
|
Sort by Date
6 Oct 2010, 4:31 pm
By Jason RantanenTeva Pharmaceuticals USA, Inc. v. [read post]
31 Jul 2008, 9:44 pm
", where I discussed some recent generic drug fiascoes discovered by the FDA involving the companies Actavis, ETHEX, and Ranbaxy. [read post]
16 Jun 2010, 3:02 pm
Zydus Pharmaceuticals USA, Inc. et al. [read post]
26 Apr 2011, 11:15 pm
Ranbaxy Laboratories manufactured an Accutane version called Sotret which has been withdrawn. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
19 May 2010, 6:15 am
Lupin Pharmaceuticals, Inc. [read post]
3 Mar 2013, 12:06 pm
Granted Anoop K Joy 1251/KOL/2006 OTSUKA PHARMACEUTICAL CO. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
6 Oct 2010, 11:43 pm
Apotex, Inc., 540 F.3d 1353 (Fed. [read post]
29 Aug 2012, 10:09 pm
District Court for the District of New Jersey concerning Wyeth Pharmaceuticals Inc. [read post]
13 May 2010, 4:58 pm
Ranbaxy Inc. et al. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
16 Jul 2012, 12:10 pm
Ranbaxy Pharma. [read post]
29 Aug 2012, 3:15 am
Ranbaxy Pharmaceuticals, Inc., 336 F.3d 1322, 1330 (Fed. [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Meda… [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid… [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
